164 related articles for article (PubMed ID: 36933326)
1. Analysis of the different subpeptidomes presented by the HLA class I molecules of the B7 supertype.
Tirado-Herranz A; Guasp P; Pastor-Moreno A; Area-Navarro M; Alvarez I
Cell Immunol; 2023 May; 387():104707. PubMed ID: 36933326
[TBL] [Abstract][Full Text] [Related]
2. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1).
Chen L; Shi H; Koftori D; Sekine T; Nicastri A; Ternette N; Bowness P
Mol Cell Proteomics; 2020 May; 19(5):871-883. PubMed ID: 32161166
[TBL] [Abstract][Full Text] [Related]
4. Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
McKinney DM; Erickson AL; Walker CM; Thimme R; Chisari FV; Sidney J; Sette A
J Immunol; 2000 Oct; 165(8):4414-22. PubMed ID: 11035079
[TBL] [Abstract][Full Text] [Related]
5. The HLA A03 Supertype and Several
de Groot NG; Heijmans CMC; de Ru AH; Otting N; Koning F; van Veelen PA; Bontrop RE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075930
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic HLA-B7-restricted peptides of hTRT.
Cortez-Gonzalez X; Sidney J; Adotevi O; Sette A; Millard F; Lemonnier F; Langlade-Demoyen P; Zanetti M
Int Immunol; 2006 Dec; 18(12):1707-18. PubMed ID: 17077179
[TBL] [Abstract][Full Text] [Related]
7. Cross-species dependence of Ly49 recognition on the supertype defining B-pocket of a class I MHC molecule.
Lavender KJ; Kane KP
J Immunol; 2006 Dec; 177(12):8578-86. PubMed ID: 17142756
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.
Røder G; Blicher T; Justesen S; Johannesen B; Kristensen O; Kastrup J; Buus S; Gajhede M
Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1300-10. PubMed ID: 17057332
[TBL] [Abstract][Full Text] [Related]
9. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
Smith KD; Lutz CT
J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
[TBL] [Abstract][Full Text] [Related]
10. Several HLA alleles share overlapping peptide specificities.
Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
[TBL] [Abstract][Full Text] [Related]
11. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.
Smith KD; Epperson DF; Lutz CT
Immunogenetics; 1996; 43(1-2):27-37. PubMed ID: 8537119
[TBL] [Abstract][Full Text] [Related]
12. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes.
Barber LD; Gillece-Castro B; Percival L; Li X; Clayberger C; Parham P
Curr Biol; 1995 Feb; 5(2):179-90. PubMed ID: 7743181
[TBL] [Abstract][Full Text] [Related]
13. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
Lim WC; Khan AM
BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
[TBL] [Abstract][Full Text] [Related]
14. Rhesus macaque MHC class I molecules present HLA-B-like peptides.
Hickman-Miller HD; Bardet W; Gilb A; Luis AD; Jackson KW; Watkins DI; Hildebrand WH
J Immunol; 2005 Jul; 175(1):367-75. PubMed ID: 15972670
[TBL] [Abstract][Full Text] [Related]
15. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
17. Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide.
Ma BJ; Kane KP
J Immunol; 2011 Sep; 187(6):3267-76. PubMed ID: 21841133
[TBL] [Abstract][Full Text] [Related]
18. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
Hillen N; Mester G; Lemmel C; Weinzierl AO; Müller M; Wernet D; Hennenlotter J; Stenzl A; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Nov; 38(11):2993-3003. PubMed ID: 18991276
[TBL] [Abstract][Full Text] [Related]
19. The Peptidome of Behçet's Disease-Associated HLA-B*51:01 Includes Two Subpeptidomes Differentially Shaped by Endoplasmic Reticulum Aminopeptidase 1.
Guasp P; Alvarez-Navarro C; Gomez-Molina P; Martín-Esteban A; Marcilla M; Barnea E; Admon A; López de Castro JA
Arthritis Rheumatol; 2016 Feb; 68(2):505-15. PubMed ID: 26360328
[TBL] [Abstract][Full Text] [Related]
20. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
